Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

SION – sionna therapeutics, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SION
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/20
07:28 am
sion
Form 10-K Sionna Therapeutics, For: Dec 31
Medium Report
Form 10-K Sionna Therapeutics, For: Dec 31
Report
3/20
07:16 am
sion
Form 8-K Sionna Therapeutics, For: Mar 20
Medium Report
Form 8-K Sionna Therapeutics, For: Mar 20
Report
3/7
10:06 am
sion
Form SEC STAFF LETTER Sionna Therapeutics,
Low Report
Form SEC STAFF LETTER Sionna Therapeutics,
Report
3/7
10:05 am
sion
Form SEC STAFF LETTER Sionna Therapeutics,
Medium Report
Form SEC STAFF LETTER Sionna Therapeutics,
Report
2/18
08:56 pm
sion
Form SCHEDULE 13D Sionna Therapeutics, Filed by: TPG GP A, LLC
Low Report
Form SCHEDULE 13D Sionna Therapeutics, Filed by: TPG GP A, LLC
Report
2/18
04:59 pm
sion
Form SCHEDULE 13D Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
Medium Report
Form SCHEDULE 13D Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
Report
2/18
04:25 pm
sion
Form SCHEDULE 13D Sionna Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low Report
Form SCHEDULE 13D Sionna Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Report
2/18
04:23 pm
sion
Form SCHEDULE 13D Sionna Therapeutics, Filed by: Enavate Sciences GP, LLC
Low Report
Form SCHEDULE 13D Sionna Therapeutics, Filed by: Enavate Sciences GP, LLC
Report
2/14
04:58 pm
sion
Form SCHEDULE 13G Sionna Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Low Report
Form SCHEDULE 13G Sionna Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Report
2/13
04:48 pm
sion
Form SCHEDULE 13D Sionna Therapeutics, Filed by: ORBIMED ADVISORS LLC
Low Report
Form SCHEDULE 13D Sionna Therapeutics, Filed by: ORBIMED ADVISORS LLC
Report
2/12
05:22 pm
sion
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: WINKELRIED JON
Low Report
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: WINKELRIED JON
Report
2/10
05:04 pm
sion
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: RA Capital Nexus Fund, L.P.
Medium Report
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: RA Capital Nexus Fund, L.P.
Report
2/10
04:29 pm
sion
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: ORBIMED ADVISORS LLC
Medium Report
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: ORBIMED ADVISORS LLC
Report
2/10
04:05 pm
sion
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: Ruddy Marcella K.
Medium Report
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: Ruddy Marcella K.
Report
2/10
04:05 pm
sion
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: Ridloff Elena
Medium Report
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: Ridloff Elena
Report
2/10
04:05 pm
sion
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: Atlas Venture Associates Opportunity II, LLC
Medium Report
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: Atlas Venture Associates Opportunity II, LLC
Report
2/10
04:05 pm
sion
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: Viney Joanne L.
Medium Report
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: Viney Joanne L.
Report
2/10
04:05 pm
sion
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: Booth Bruce
Medium Report
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: Booth Bruce
Report
2/10
04:05 pm
sion
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: Cloonan Michael
Medium Report
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: Cloonan Michael
Report
2/10
04:05 pm
sion
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: Thompson Peter A.
Medium Report
Form 4 Sionna Therapeutics, For: Feb 10 Filed by: Thompson Peter A.
Report
2/10
04:05 pm
sion
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: McKee Charlotte
Medium Report
Form 4 Sionna Therapeutics, For: Feb 06 Filed by: McKee Charlotte
Report
2/10
04:01 pm
sion
Form 8-K Sionna Therapeutics, For: Feb 06
Medium Report
Form 8-K Sionna Therapeutics, For: Feb 06
Report
2/7
04:46 pm
sion
Form S-8 Sionna Therapeutics,
Medium Report
Form S-8 Sionna Therapeutics,
Report
2/7
04:02 pm
sion
Form 424B4 Sionna Therapeutics,
Medium Report
Form 424B4 Sionna Therapeutics,
Report
2/7
06:02 am
sion
Form EFFECT Sionna Therapeutics,
Neutral Report
Form EFFECT Sionna Therapeutics,
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2025, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0